Company / Working Capital per Share
Protalix BioTherapeutics, Inc. Working Capital per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.53
FY2025
5-year range
$0.27 / $0.82
FY2021-FY2025
Trend
+12.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital per Share has increased for 3 consecutive years, from $0.27 in FY2022 to $0.53 in FY2025.
Based on SEC 10-K filings.
0.53 in FY2025 with a 10-year CAGR of -4.0%.
Improved from $0.45 to $0.53 over the past 2 years.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- +24.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -4.0%
Key checks
Key Insights
- Protalix BioTherapeutics, Inc.'s working capital per share has grown for 3 consecutive years.
- In FY2025, working capital per share increased 12.1% year-over-year.
- Peak working capital per share was recorded in FY2021.
- Lowest working capital per share in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.53 | +12.1% |
| FY2024 | $0.47 | +4.1% |
| FY2023 | $0.45 | +66.0% |
| FY2022 | $0.27 | -66.6% |
| FY2021 | $0.82 | +139.5% |
| FY2020 | -$2.07 | -299.6% |
| FY2019 | -$0.52 | -261.4% |
| FY2017 | $0.32 | +467.2% |
| FY2016 | $0.06 | -92.9% |
| FY2015 | $0.80 | +89.8% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026